Skip to main content
profile image
Selected Works of Santiago Aparo
Article
Assessment of the Fanconi Anemia Repair Pathway as a Predictor of Clinical Activity of Pembrolizumab (PEM).
Journal of Clinical Oncology /American Society of Clinical Oncology (ASCO) Annual Meeting (2019)
  • Santiago Aparo, Baptist Health South Florida
  • Miguel Angel Villalona-Calero, Baptist Hospital of Miami
  • John Paul Diaz, Miami Cancer Institute, Miami, FL;
  • Zuanel Diaz, Miami Cancer Institute, Miami, FL;
  • Wenrui Duan, FIU Herbert Wertheim College of Medicine
  • Eric Douglas Schroeder, Miami Cancer Institute, Miami, FL;
  • Troy Antony Gatcliffe, Baptist Hospital of Miami
  • Alfredo Pedro Alonso, Baptist Hospital of Miami
  • Sebastian Cuitiva, Baptist Hospital of Miami
  • Federico Albrecht, Miami Cancer Institute, Miami, FL;
  • Siddhartha A. Venkatappa, Baptist Hospital of Miami
  • Victor D Guardiola Amado, Baptist Health South Florida
  • Michael B. Troner, Baptist Hospital of Miami
  • Sara M. Garrido, Baptist Hospital of Miami
  • Gail Walker, Baptist Hospital of Miami
  • Muni Rubens, Baptist Hospital of Miami
  • Fernando I. De Zarraga, Baptist Hospital of Miami
  • Hao Vuong, Radiology Specialists of South Florida, Miami, FL;
Link
Disciplines
Publication Date
2019
Citation Information
Santiago Aparo, Miguel Angel Villalona-Calero, John Paul Diaz, Zuanel Diaz, et al.. "Assessment of the Fanconi Anemia Repair Pathway as a Predictor of Clinical Activity of Pembrolizumab (PEM)." Journal of Clinical Oncology /American Society of Clinical Oncology (ASCO) Annual Meeting Vol. 37 (2019) p. 2555 - 2555
Available at: http://works.bepress.com/santiago-aparo/43/